Richard S.E. Keefe

Publications

• Validation of the Persian Version of the Brief Assessment of Cognition in Schizophrenia in Patients with Schizophrenia and Healthy Controls
  Psychiatry and Clinical Neurosciences. Feb, 2014  |   Pubmed ID: 24552637
• Neuropsychological Decline in Schizophrenia from the Premorbid to the Postonset Period: Evidence from a Population-representative Longitudinal Study
  The American Journal of Psychiatry. Jan, 2014  |   Pubmed ID: 24030246
• The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR Perspective
  Schizophrenia Research. Dec, 2013  |   Pubmed ID: 24139196
• Unraveling the Relationship Between Obesity, Schizophrenia and Cognition
  Schizophrenia Research. Dec, 2013  |   Pubmed ID: 24119725
• Elevated Antisaccade Error Rate As an Intermediate Phenotype for Psychosis Across Diagnostic Categories
  Schizophrenia Bulletin. Sep, 2013  |   Pubmed ID: 24080895
• Preserved Working Memory and Altered Brain Activation in Persons at Risk for Psychosis
  The American Journal of Psychiatry. Nov, 2013  |   Pubmed ID: 24077560
• Microvascular Abnormality in Schizophrenia As Shown by Retinal Imaging
  The American Journal of Psychiatry. Dec, 2013  |   Pubmed ID: 24030514
• Issues and Perspectives in Designing Clinical Trials for Negative Symptoms in Schizophrenia
  Schizophrenia Research. Nov, 2013  |   Pubmed ID: 24028744
• Social Cognition As a Mediator Between Neurocognition and Functional Outcome in Individuals at Clinical High Risk for Psychosis
  Schizophrenia Research. Nov, 2013  |   Pubmed ID: 24012459
• Schizophrenia is a Cognitive Illness: Time for a Change in Focus
  JAMA Psychiatry. Oct, 2013  |   Pubmed ID: 23925787
• Brief Assessment of Cognition in Schizophrenia: Normative Data in an English-Speaking Ethnic Chinese Sample
  Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. Aug, 2013  |   Pubmed ID: 23912998
• Defining a Clinically Meaningful Effect for the Design and Interpretation of Randomized Controlled Trials
  Innovations in Clinical Neuroscience. May, 2013  |   Pubmed ID: 23882433
• Altered Striatal Functional Connectivity in Subjects With an At-Risk Mental State for Psychosis
  Schizophrenia Bulletin. Jul, 2013  |   Pubmed ID: 23861539
• Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study
  The American Journal of Psychiatry. Nov, 2013  |   Pubmed ID: 23771174
• Cognition in Schizophrenia: Summary Nice Consultation Meeting 2012
  European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. Aug, 2013  |   Pubmed ID: 23684476
• Interview-based Assessment of Cognition in Schizophrenia: Applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in Different Phases of Illness and Settings of Care
  Schizophrenia Research. May, 2013  |   Pubmed ID: 23510596
• Applicability of the MATRICS Consensus Cognitive Battery in Singapore
  The Clinical Neuropsychologist. 2013  |   Pubmed ID: 23362823
• The Course of Cognitive Functioning over Six Months in Individuals at Clinical High Risk for Psychosis
  Psychiatry Research. Apr, 2013  |   Pubmed ID: 23159196
• Formulation of the Age-education Index: Measuring Age and Education Effects in Neuropsychological Performance
  Psychological Assessment. Mar, 2013  |   Pubmed ID: 23148648
• How Specific Are Negative Symptoms and Cognitive Impairment in Schizophrenia? An Analysis of PANSS and SCoRS
  Cognitive Neuropsychiatry. May, 2013  |   Pubmed ID: 23145794
• The Cognitive Assessment Interview (CAI): Reliability and Validity of a Brief Interview-based Measure of Cognition
  Schizophrenia Bulletin. May, 2013  |   Pubmed ID: 22328641
• Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data
  Schizophrenia Bulletin. May, 2013  |   Pubmed ID: 22290266
• Clinical Trials of Potential Cognitive-enhancing Drugs in Schizophrenia: What Have We Learned So Far?
  Schizophrenia Bulletin. Mar, 2013  |   Pubmed ID: 22114098
• Standardizing the Use of the Continuous Performance Test in Schizophrenia Research: a Validation Study
  Schizophrenia Research. Dec, 2012  |   Pubmed ID: 23040735
• Cognitive Impairment in Schizophrenia
  Handbook of Experimental Pharmacology. 2012  |   Pubmed ID: 23027411
• Persistent Cannabis Users Show Neuropsychological Decline from Childhood to Midlife
  Proceedings of the National Academy of Sciences of the United States of America. Oct, 2012  |   Pubmed ID: 22927402
• Validation of a Clinician Questionnaire to Assess Reasons for Antipsychotic Discontinuation and Continuation Among Patients with Schizophrenia
  Psychiatry Research. Dec, 2012  |   Pubmed ID: 22841345
• Feasibility and Pilot Efficacy Results from the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial
  The Journal of Clinical Psychiatry. Jul, 2012  |   Pubmed ID: 22687548
• A Randomized Controlled Trial of Allopurinol Vs. Placebo Added on to Antipsychotics in Patients with Schizophrenia or Schizoaffective Disorder
  Schizophrenia Research. Jun, 2012  |   Pubmed ID: 22483162
• Clues to the Cognitive and Perceptual Origins of Social Isolation and Psychosis in Schizophrenia
  The American Journal of Psychiatry. Apr, 2012  |   Pubmed ID: 22476674
• Effect of the Neuroprotective Peptide Davunetide (AL-108) on Cognition and Functional Capacity in Schizophrenia
  Schizophrenia Research. Apr, 2012  |   Pubmed ID: 22169248
• The Singapore Flagship Programme in Translational and Clinical Research in Psychosis
  Early Intervention in Psychiatry. Nov, 2011  |   Pubmed ID: 22032547
• Substance Use and Schizophrenia: Adverse Correlates in the CATIE Study Sample
  Schizophrenia Research. Nov, 2011  |   Pubmed ID: 21872443
• Cognitive Effects of Atypical Antipsychotic Medications in Patients with Alzheimer's Disease: Outcomes from CATIE-AD
  The American Journal of Psychiatry. Aug, 2011  |   Pubmed ID: 21572163
• Longitudinal Consent-related Abilities Among Research Participants with Schizophrenia: Results from the CATIE Study
  Schizophrenia Research. Aug, 2011  |   Pubmed ID: 21561740
• Comprehensive Model of How Reality Distortion and Symptoms Occur in Schizophrenia: Could Impairment in Learning-dependent Predictive Perception Account for the Manifestations of Schizophrenia?
  Psychiatry and Clinical Neurosciences. Jun, 2011  |   Pubmed ID: 21447049
• Bifactor and Item Response Theory Analyses of Interviewer Report Scales of Cognitive Impairment in Schizophrenia
  Psychological Assessment. Mar, 2011  |   Pubmed ID: 21381848
• Performance and Interview-based Assessments of Cognitive Change in a Randomized, Double-blind Comparison of Lurasidone Vs. Ziprasidone
  Schizophrenia Research. Apr, 2011  |   Pubmed ID: 21277745
• Methodological Issues in Negative Symptom Trials
  Schizophrenia Bulletin. Mar, 2011  |   Pubmed ID: 21270473
• The MCCB Impairment Profile for Schizophrenia Outpatients: Results from the MATRICS Psychometric and Standardization Study
  Schizophrenia Research. Mar, 2011  |   Pubmed ID: 21159492
• A Randomized Clinical Trial of MK-0777 for the Treatment of Cognitive Impairments in People with Schizophrenia
  Biological Psychiatry. Mar, 2011  |   Pubmed ID: 21145041
• Failures in Learning-dependent Predictive Perception As the Key Cognitive Vulnerability to Psychosis in Schizophrenia
  Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Jan, 2011  |   Pubmed ID: 21116261
• Criminal Justice System Involvement Among People with Schizophrenia
  Community Mental Health Journal. Dec, 2011  |   Pubmed ID: 21113799
• Genome-wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
  Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Feb, 2011  |   Pubmed ID: 21107309
• Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site Antipsychotic Schizophrenia Clinical Trial
  Schizophrenia Research. Feb, 2011  |   Pubmed ID: 21075600
• Treatment Outcomes of Patients with Tardive Dyskinesia and Chronic Schizophrenia
  The Journal of Clinical Psychiatry. Mar, 2011  |   Pubmed ID: 20816031
• The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-enhancing Drugs: What Do We Know 5 Years Later?
  Schizophrenia Bulletin. Nov, 2011  |   Pubmed ID: 20410237
• Report from the Working Group Conference on Multisite Trial Design for Cognitive Remediation in Schizophrenia
  Schizophrenia Bulletin. Sep, 2011  |   Pubmed ID: 20194249
• A Brief Cognitive Assessment Tool for Schizophrenia: Construction of a Tool for Clinicians
  Schizophrenia Bulletin. May, 2011  |   Pubmed ID: 19776205
• Differential Effects of Emotional Information on Interference Task Performance Across the Life Span
  Frontiers in Aging Neuroscience. 2010  |   Pubmed ID: 20953250
• Armodafinil As Adjunctive Therapy in Adults with Cognitive Deficits Associated with Schizophrenia: a 4-week, Double-blind, Placebo-controlled Study
  The Journal of Clinical Psychiatry. Nov, 2010  |   Pubmed ID: 20816042
• The Cognitive Assessment Interview (CAI): Development and Validation of an Empirically Derived, Brief Interview-based Measure of Cognition
  Schizophrenia Research. Aug, 2010  |   Pubmed ID: 20542412
• Neuropsychology of the Prodrome to Psychosis in the NAPLS Consortium: Relationship to Family History and Conversion to Psychosis
  Archives of General Psychiatry. Jun, 2010  |   Pubmed ID: 20530007
• No Association of the Serotonin Transporter Polymorphisms 5-HTTLPR and RS25531 with Schizophrenia or Neurocognition
  American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. Jul, 2010  |   Pubmed ID: 20468059
• The Schizophrenia Cognition Rating Scale: Validation of an Interview-based Assessment of Cognitive Functioning in Asian Patients with Schizophrenia
  Psychiatry Research. Jun, 2010  |   Pubmed ID: 20451258
• Etiological and Clinical Features of Childhood Psychotic Symptoms: Results from a Birth Cohort
  Archives of General Psychiatry. Apr, 2010  |   Pubmed ID: 20368509
• Circumstances Under Which Practice Does Not Make Perfect: a Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies
  Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Apr, 2010  |   Pubmed ID: 20090669
• Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: a 30-year Study
  The American Journal of Psychiatry. Feb, 2010  |   Pubmed ID: 20048021
• Anticipating DSM-V: Opportunities and Challenges for Cognition and Psychosis
  Schizophrenia Bulletin. Jan, 2010  |   Pubmed ID: 19923191
• The Effects of Antipsychotic Medications on Emotion Perception in Patients with Chronic Schizophrenia in the CATIE Trial
  Schizophrenia Research. Nov, 2009  |   Pubmed ID: 19766459
• Memory-prediction Errors and Their Consequences in Schizophrenia
  Neuropsychology Review. Sep, 2009  |   Pubmed ID: 19575296
• Measuring Memory-prediction Errors and Their Consequences in Youth at Risk for Schizophrenia
  Annals of the Academy of Medicine, Singapore. May, 2009  |   Pubmed ID: 19521641
• Psychosocial Factors in the Neurobiology of Schizophrenia: a Selective Review
  Annals of the Academy of Medicine, Singapore. May, 2009  |   Pubmed ID: 19521639
• Proof-of-concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia
  Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Jul, 2009  |   Pubmed ID: 19339966
• A Genome-wide Investigation of SNPs and CNVs in Schizophrenia
  PLoS Genetics. Feb, 2009  |   Pubmed ID: 19197363
• Pharmacogenetics of Antipsychotic Response in the CATIE Trial: a Candidate Gene Analysis
  European Journal of Human Genetics : EJHG. Jul, 2009  |   Pubmed ID: 19156168
• Results of Phase 3 of the CATIE Schizophrenia Trial
  Schizophrenia Research. Jan, 2009  |   Pubmed ID: 19027269
• CMINDS Does Not Have Identical Tests to the CATIE and MATRICS Batteries. Commentary on O'Halloran Et Al
  Schizophrenia Research. Feb, 2009  |   Pubmed ID: 19013770
• Development and Psychometric Performance of the Schizophrenia Objective Functioning Instrument: an Interviewer Administered Measure of Function
  Schizophrenia Research. Feb, 2009  |   Pubmed ID: 19013769
• Abbreviated Neuropsychological Assessment in Schizophrenia: Prediction of Different Aspects of Outcome
  Journal of Clinical and Experimental Neuropsychology. May, 2009  |   Pubmed ID: 18720182
• Cognition and Schizophrenia: is There a Role for Cognitive Assessments in Diagnosis and Treatment?
  Psychiatry (Edgmont (Pa. : Township)). Dec, 2008  |   Pubmed ID: 19724777
• Extrapyramidal Side-effects of Antipsychotics in a Randomised Trial
  The British Journal of Psychiatry : the Journal of Mental Science. Oct, 2008  |   Pubmed ID: 18827289
• Neuropsychological Course in the Prodrome and First Episode of Psychosis: Findings from the PRIME North America Double Blind Treatment Study
  Schizophrenia Research. Oct, 2008  |   Pubmed ID: 18774696
• Implementation Considerations for Multisite Clinical Trials with Cognitive Neuroscience Tasks
  Schizophrenia Bulletin. Jul, 2008  |   Pubmed ID: 18495645
• Norms and Standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)
  Schizophrenia Research. Jul, 2008  |   Pubmed ID: 18495435
• Should Cognitive Impairment Be Included in the Diagnostic Criteria for Schizophrenia?
  World Psychiatry : Official Journal of the World Psychiatric Association (WPA). Feb, 2008  |   Pubmed ID: 18458774
• What CATIE Found: Results from the Schizophrenia Trial
  Psychiatric Services (Washington, D.C.). May, 2008  |   Pubmed ID: 18451005
• Relationship of Cognition and Psychopathology to Functional Impairment in Schizophrenia
  The American Journal of Psychiatry. Aug, 2008  |   Pubmed ID: 18450928
• The Neuregulin 1 Promoter Polymorphism Rs6994992 is Not Associated with Chronic Schizophrenia or Neurocognition
  American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. Oct, 2008  |   Pubmed ID: 18286587
• Efficiency of the CATIE and BACS Neuropsychological Batteries in Assessing Cognitive Effects of Antipsychotic Treatments in Schizophrenia
  Journal of the International Neuropsychological Society : JINS. Mar, 2008  |   Pubmed ID: 18282319
• Employment Outcomes in a Randomized Trial of Second-generation Antipsychotics and Perphenazine in the Treatment of Individuals with Schizophrenia
  The Journal of Behavioral Health Services & Research. Apr, 2008  |   Pubmed ID: 18246429
• The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
  The American Journal of Psychiatry. Feb, 2008  |   Pubmed ID: 18172019
• The MATRICS Consensus Cognitive Battery, Part 2: Co-norming and Standardization
  The American Journal of Psychiatry. Feb, 2008  |   Pubmed ID: 18172018
• Functional Co-primary Measures for Clinical Trials in Schizophrenia: Results from the MATRICS Psychometric and Standardization Study
  The American Journal of Psychiatry. Feb, 2008  |   Pubmed ID: 18172017
• Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/practice Effects in a 12-week, Randomized, Double-blind, Placebo-controlled Trial
  Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. May, 2008  |   Pubmed ID: 17625502
• Cognitive Deficits in Patients with Schizophrenia: Effects and Treatment
  The Journal of Clinical Psychiatry. 2007  |   Pubmed ID: 18284272
• Cognition As an Outcome Measure in Schizophrenia
  The British Journal of Psychiatry. Supplement. Aug, 2007  |   Pubmed ID: 18019044
• Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: a Randomized, Double-blind 52-week Comparison
  The American Journal of Psychiatry. Jul, 2007  |   Pubmed ID: 17606658
• How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment?
  Schizophrenia Bulletin. Jul, 2007  |   Pubmed ID: 17567627
• Neurocognitive Effects of Antipsychotic Medications in Patients with Chronic Schizophrenia in the CATIE Trial
  Archives of General Psychiatry. Jun, 2007  |   Pubmed ID: 17548746
• AKT1 and Neurocognition in Schizophrenia
  The Australian and New Zealand Journal of Psychiatry. Feb, 2007  |   Pubmed ID: 17464696
• Validation of the French Version of the BACS (the Brief Assessment of Cognition in Schizophrenia) Among 50 French Schizophrenic Patients
  European Psychiatry : the Journal of the Association of European Psychiatrists. Sep, 2007  |   Pubmed ID: 17434715
• Effects of Antipsychotic Medications on Psychosocial Functioning in Patients with Chronic Schizophrenia: Findings from the NIMH CATIE Study
  The American Journal of Psychiatry. Mar, 2007  |   Pubmed ID: 17329467
• Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients with Chronic Schizophrenia After Discontinuing Perphenazine: a CATIE Study
  The American Journal of Psychiatry. Mar, 2007  |   Pubmed ID: 17329466
• Risperidone and Cognitive Function in Children with Disruptive Behavior Disorders
  Biological Psychiatry. Aug, 2007  |   Pubmed ID: 17210137
• NCAM1 and Neurocognition in Schizophrenia
  Biological Psychiatry. Apr, 2007  |   Pubmed ID: 17161382
• Missing the Sweet Spot Disengagement in Schizophrenia
  Psychiatry (Edgmont (Pa. : Township)). Jul, 2006  |   Pubmed ID: 20975816
• Cost-effectiveness of Second-generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia
  The American Journal of Psychiatry. Dec, 2006  |   Pubmed ID: 17151158
• A Longitudinal Study of Neurocognitive Function in Individuals At-risk for Psychosis
  Schizophrenia Research. Dec, 2006  |   Pubmed ID: 16930949
• Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
  Psychiatric Services (Washington, D.C.). Aug, 2006  |   Pubmed ID: 16870959
• Insight in First-episode Psychosis
  Psychological Medicine. Oct, 2006  |   Pubmed ID: 16740175
• Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial
  Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Sep, 2006  |   Pubmed ID: 16641947
• Optimization of a Multinomial Model for Investigating Hallucinations and Delusions with Source Monitoring
  Schizophrenia Research. Jul, 2006  |   Pubmed ID: 16626938
• Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients with Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic
  The American Journal of Psychiatry. Apr, 2006  |   Pubmed ID: 16585435
• Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients with Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
  The American Journal of Psychiatry. Apr, 2006  |   Pubmed ID: 16585434
• The Schizophrenia Cognition Rating Scale: an Interview-based Assessment and Its Relationship to Cognition, Real-world Functioning, and Functional Capacity
  The American Journal of Psychiatry. Mar, 2006  |   Pubmed ID: 16513863
• The Relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to Functional Capacity and Real-world Functional Outcome
  Journal of Clinical and Experimental Neuropsychology. Feb, 2006  |   Pubmed ID: 16484097
• One-year Double-blind Study of the Neurocognitive Efficacy of Olanzapine, Risperidone, and Haloperidol in Schizophrenia
  Schizophrenia Research. Jan, 2006  |   Pubmed ID: 16202565
• Long-term Neurocognitive Effects of Olanzapine or Low-dose Haloperidol in First-episode Psychosis
  Biological Psychiatry. Jan, 2006  |   Pubmed ID: 16140282
• Measuring Outcome Priorities and Preferences in People with Schizophrenia
  The British Journal of Psychiatry : the Journal of Mental Science. Dec, 2005  |   Pubmed ID: 16319405
• Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
  The New England Journal of Medicine. Sep, 2005  |   Pubmed ID: 16172203
• Clinical Correlates of Tardive Dyskinesia in Schizophrenia: Baseline Data from the CATIE Schizophrenia Trial
  Schizophrenia Research. Dec, 2005  |   Pubmed ID: 16171976
• The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical Comparison of Subgroups with and Without the Metabolic Syndrome
  Schizophrenia Research. Dec, 2005  |   Pubmed ID: 16125372
• A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia
  Schizophrenia Bulletin. Jan, 2005  |   Pubmed ID: 15888422
• Antipsychotic Drug Effects on Brain Morphology in First-episode Psychosis
  Archives of General Psychiatry. Apr, 2005  |   Pubmed ID: 15809403
• Defining a Cognitive Function Decrement in Schizophrenia
  Biological Psychiatry. Mar, 2005  |   Pubmed ID: 15780858
• Approaching a Consensus Cognitive Battery for Clinical Trials in Schizophrenia: the NIMH-MATRICS Conference to Select Cognitive Domains and Test Criteria
  Biological Psychiatry. Sep, 2004  |   Pubmed ID: 15336511
• Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-episode Psychosis: a Randomized, Double-blind Trial of Olanzapine Versus Low Doses of Haloperidol
  The American Journal of Psychiatry. Jun, 2004  |   Pubmed ID: 15169686
• The Brief Assessment of Cognition in Schizophrenia: Reliability, Sensitivity, and Comparison with a Standard Neurocognitive Battery
  Schizophrenia Research. Jun, 2004  |   Pubmed ID: 15099610
• Cognitive Functioning in Schizophrenia: a Consensus Statement on Its Role in the Definition and Evaluation of Effective Treatments for the Illness
  The Journal of Clinical Psychiatry. Mar, 2004  |   Pubmed ID: 15096076
• Neurocognitive Assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project Schizophrenia Trial: Development, Methodology, and Rationale
  Schizophrenia Bulletin. 2003  |   Pubmed ID: 12908660
• Source Monitoring Improvement in Patients with Schizophrenia Receiving Antipsychotic Medications
  Psychopharmacology. Sep, 2003  |   Pubmed ID: 12759802
• Source-monitoring Deficits for Self-generated Stimuli in Schizophrenia: Multinomial Modeling of Data from Three Sources
  Schizophrenia Research. Sep, 2002  |   Pubmed ID: 12165376
• Sensory Acuity and Reasoning in Delusional Disorder
  Comprehensive Psychiatry. May-Jun, 2002  |   Pubmed ID: 11994833